Product logins

Find logins to all Clarivate products below.


Dr. Srikanth Rajagopal

Managing Partner and Vice President, Commercial Consulting Services

Doc is an experienced management consultant, client partner and practice leader, with close to 20 years of experience selling, leading & delivering a range of product and portfolio strategy, transaction advisory, evidence generation, pricing and market access, commercial strategy and transformation, and business innovation engagements for biopharmaceutical industry clients and their investors across the US, Europe, Asia-Pacific and Japan.​

He believes in a structured, collaborative, expertise-based approach to problem-solving and solution development. Doc partners with colleagues across Clarivate to harness our deep expertise in global healthcare systems, policy, drug development and approval, therapy areas and indications, business development and licensing, pricing and reimbursement systems and processes, customer engagement models and data and advanced analytics to deliver exceptional, impactful outcomes for our clients.​

He previously led Clarivate Europe, Asia-Pacific and Japan Commercial Consulting business, and has held positions of increasing responsibility at global consulting firms such as Guidehouse, IQVIA and Strategic Decisions Group (SDG).

By way of academic qualifications, Doc holds an MBA from the Indian Institute of Management, Ahmedabad and an MBBS (MD equivalent) from the University of Mumbai.


arrow_forward
Get in touch with Srikanth

Latest news

News March 30, 2026
Clarivate Selected by University of Texas at Dallas Libraries to Provide Alma Specto

Alma Specto, an AI-native digital collection and exhibition platform offers UT Dallas Libraries a scalable, flexible and future-ready solution, expanding the reach of its Special Collections to new audiences London,…

News March 26, 2026
Clarivate Reveals the AI50 – the Organizations Leading Artificial Intelligence Invention

London, U.K. March, 26, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the Clarivate AI50, a new data-driven benchmark of organizations demonstrating exceptional leadership in…

News March 25, 2026
Annual Report to Identify 189 Global Engineering Fronts Released by Clarivate, the Chinese Academy of Engineering and the Higher Education Press of China

A comprehensive outlook on engineering innovations London, U.K. March 25, 2026. Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, the Chinese Academy of Engineering (CAE) and the…

Related resources

How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.
Managing uncertainty for medicine in Washington Managing uncertainty for medicine in Washington
Blog May 15, 2025
Managing uncertainty for medicine in Washington
Clinical research Early drug development research Market Access Pharma Portfolio strategy Research Research and development Research commercialization Research evaluation and management
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Blog April 2, 2025
Navigating uncertainty: What’s keeping healthcare execs up at night in this new era
Market Access Pharma Portfolio strategy Regulatory Research commercialization
Five Medtech Trends to Watch in 2025 Five Medtech Trends to Watch in 2025
Blog February 11, 2025
Five Medtech Trends to Watch in 2025
Medical technology Medtech Medtech Resource Center